These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 38267771)

  • 1. Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances.
    Iseas S; Mariano G; Gros L; Baba-Hamed N; De Parades V; Adam J; Raymond E; Abba MC
    Mol Diagn Ther; 2024 Mar; 28(2):201-214. PubMed ID: 38267771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
    Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
    Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
    Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
    Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review.
    Power Foley M; Kelly ME; Kerr C; Kennedy C; Gallagher D; Gillham C; Mehigan BJ; McCormick PH; Bergin C; Larkin JO
    Int J Colorectal Dis; 2020 Oct; 35(10):1855-1864. PubMed ID: 32500433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
    Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
    Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice.
    Bull-Henry K; Morris B; Buchwald UK
    Curr Opin Gastroenterol; 2020 Sep; 36(5):393-401. PubMed ID: 32701604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV and anal cancer in HIV-infected individuals: a review.
    Schim van der Loeff MF; Mooij SH; Richel O; de Vries HJ; Prins JM
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):250-62. PubMed ID: 24990810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
    Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer.
    Congedo A; Mallardi D; Danti G; De Muzio F; Granata V; Miele V
    Tomography; 2023 Sep; 9(5):1694-1710. PubMed ID: 37736988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.
    Smaglo BG; Tesfaye A; Halfdanarson TR; Meyer JE; Wang J; Gatalica Z; Reddy S; Arguello D; Boland PM
    Oncotarget; 2015 Dec; 6(41):43594-604. PubMed ID: 26498363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal squamous cell carcinoma - State of the art management and future perspectives.
    Martin D; Balermpas P; Winkelmann R; Rödel F; Rödel C; Fokas E
    Cancer Treat Rev; 2018 Apr; 65():11-21. PubMed ID: 29494827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
    Cacheux W; Lièvre A; Richon S; Vacher S; El Alam E; Briaux A; El Botty R; Mariani P; Buecher B; Schnitzler A; Barbazan J; Roman-Roman S; Bièche I; Dangles-Marie V
    Int J Cancer; 2019 Oct; 145(7):1852-1859. PubMed ID: 30714617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.